Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) has issued an announcement.
EBOS Group Limited announced a change in the director’s interest, with Elizabeth Coutts acquiring 3,000 ordinary shares through an on-market trade. This acquisition increases her indirect interest in the company, reflecting a potential vote of confidence in the company’s future performance and stability.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including pharmaceuticals, medical equipment, and animal health products. The company focuses on serving markets in Australia and New Zealand, positioning itself as a key player in these sectors.
Average Trading Volume: 135,982
Technical Sentiment Signal: Sell
Current Market Cap: A$5.19B
See more insights into EBO stock on TipRanks’ Stock Analysis page.